Advanced Cancer Patients’ Understanding and Perceptions of Phase I Clinical Trials

REFERENCES

• Agrawal M, Emanuel EJ. Ethics of phase 1 oncology studies: reexamining the arguments and data. JAMA 2003;290(8):1075–82.
   PubMed Web of Science ®Google Scholar
• Cheng JDHitt J, Koczwara B, Schulman KA, Burnett CB, Gaskin DJ,Impact of quality of life on patient expectations regarding phase I clinical trials. J Clin Oncol 2000;18(2):421–8.
   PubMed Web of Science ®Google Scholar
• Sekine I,Yamamoto N, Kunitoh H, Ohe Y, Tamura T, Kodama T,Relationship between objective responses in phase I trials and potential efficacy of non-specific cytotoxic investigational new drugs. Ann Oncol 2002;13(8):1300–6.
   PubMed Web of Science ®Google Scholar
• Von Hoff DD, Turner J. Response rates, duration of response, and dose response effects in phase I studies of antineoplastics. Invest New Drugs 1991;9(1):115–22.
   PubMed Web of Science ®Google Scholar
• Roberts TG, Jr., Goulart BH, Squitieri L, Stallings SC, Halpern EF, Chabner BA,Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA 2004;292(17):2130–40.
   PubMed Web of Science ®Google Scholar
• Estey E,Hoth D, Simon R, Marsoni S, Leyland-Jones B, Wittes R.Therapeutic response in phase I trials of antineoplastic agents. Cancer Treat Rep 1986;70(9):1105–15.
   PubMedGoogle Scholar
• Decoster G,Stein G,Holdener EE. Responses and toxic deaths in phase I clinical trials. Ann Oncol 1990;1(3):175–81.
   PubMed Web of Science ®Google Scholar
• Weinfurt KP,Seils DM, Tzeng JP, Compton KL, Sulmasy DP, Astrow AB,Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent. Med Decis Making 2008;28(4):575–81.
   PubMed Web of Science ®Google Scholar
• Nurgat ZA,Craig W, Campbell NC, Bissett JD, Cassidy J, Nicolson MC.Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. Br J Cancer 2005;92(6):1001–5.
   PubMed Web of Science ®Google Scholar
• Weinfurt KP,Sulmasy DP, Schulman KA, Meropol NJ.Patient expectations of benefit from phase I clinical trials: linguistic considerations in diagnosing a therapeutic misconception. Theor Med Bioeth 2003;24(4):329–44.
   PubMed Web of Science ®Google Scholar
• Sulmasy DP,Astrow AB, He MK, Seils DM, Meropol NJ, Micco E,The culture of faith and hope: patients’ justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials. Cancer 2010;116(15):3702–11.
   PubMed Web of Science ®Google Scholar
• Weinfurt KP,Castel LD, Li Y, Sulmasy DP, Balshem AM, Benson AB 3rd,The correlation between patient characteristics and expectations of benefit from Phase I clinical trials. Cancer 2003;98(1):166–75.
   PubMed Web of Science ®Google Scholar
• Meropol NJ,Weinfurt KP, Burnett CB, Balshem A, Benson AB 3rd, Corbett S,Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol 2003;21(13):2589–96.
   PubMed Web of Science ®Google Scholar
• Daugherty C,Ratain MJ, Grochowski E, Stocking C, Kodish E, Mick R,Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol 1995;13(5): 1062–72.
   PubMed Web of Science ®Google Scholar
• Daugherty CK. Ethical issues in the development of new agents. Invest New Drugs 1999;17(2):145–53.
   PubMed Web of Science ®Google Scholar
• Daugherty CK. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective. J Clin Oncol 1999;17(5):1601–17.
   PubMed Web of Science ®Google Scholar
• Tannock IF. The recruitment of patients into clinical trials. Br J Cancer 1995;71(6):1134–5.
   PubMed Web of Science ®Google Scholar
• Schutta KM,Burnett CB. Factors that influence a patient's decision to participate in a phase I cancer clinical trial. Oncol Nurs Forum 2000;27(9):1435–8.
   PubMedGoogle Scholar
• Malik L,Kuo J, Yip D, Mejia A.How well informed is the informed consent for cancer clinical trials? Clin Trials 2014;11(6): 686–8.
   PubMed Web of Science ®Google Scholar
• Horng S,Emanuel EJ, Wilfond B, Rackoff J, Martz K, Grady C.Descriptions of benefits and risks in consent forms for phase 1 oncology trials. N Engl J Med 2002;347(26):2134–40.
   PubMed Web of Science ®Google Scholar
• Beardsley E,Jefford M,Mileshkin L. Longer consent forms for clinical trials compromise patient understanding: so why are they lengthening?. J Clin Oncol 2007;25(9):e13–4.
   PubMed Web of Science ®Google Scholar
• National Center for Education Statistics. National Assessment of Adult Literacy [ cited 2014 July]; Available from: https://nces.ed.gov/naal/estimates/StateEstimates.aspx.
   Google Scholar
• O'Connor AM,Rostom A, Fiset V, Tetroe J, Entwistle V, Llewellyn-Thomas H,Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ 1999;319(7212): 731–4.
   PubMed Web of Science ®Google Scholar
• Whelan T,Sawka C, Levine M, Gafni A, Reyno L, Willan A,Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. J Natl Cancer Inst 2003;95(8):581–7.
   PubMed Web of Science ®Google Scholar
• Elwyn G,O'Connor A, Stacey D, Volk R, Edwards A, Coulter A,Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 2006;333(7565):417.
   PubMed Web of Science ®Google Scholar
• Truong TH,Weeks JC, Cook EF, Joffe S.Altruism among participants in cancer clinical trials. Clin Trials 2011;8(5):616–23.
   PubMed Web of Science ®Google Scholar
• Penman DT,Holland JC, Bahna GF, Morrow G, Schmale AH, Derogatis LR,Informed consent for investigational chemotherapy: patients’ and physicians’ perceptions. J Clin Oncol 1984;2(7):849–55.
   PubMed Web of Science ®Google Scholar
• Mohd Noor A,Sarker D, Vizor S, McLennan B, Hunter S, Suder A,Effect of patient socioeconomic status on access to early-phase cancer trials. J Clin Oncol 2013;31(2):224–30.
   PubMed Web of Science ®Google Scholar